We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Pharmacy Benefits Merger Forms Management Powerhouse

By HospiMedica International staff writers
Posted on 02 Nov 2011
Express Scripts (St. Louis, MO, USA) is set to buy rival Medco Health Solutions (Franklin Lakes, NJ, USA) for US$29.1 billion, which would create the largest pharmacy benefit management (PBM) company in the United States.

The combined company would be the industry's largest, with 1.6 billion annual prescription claims, while CVS Caremark (Woonsocket, RI, USA) would be second at 940 million. The merger between two of the three largest PBMs will create a clear industry leader and could encounter antitrust hurdles, since the combined company would have an estimated 30% of the market for prescription claims. As a result, a US Senate antitrust subcommittee plans to hold a hearing on the proposed merger of the PBMs, since the merger would create a company with more than $100 billion in annual revenue.

Healthcare market analysts say the deal could fundamentally change the dynamics of the market for overseeing prescription drug use for health plans and employers. The US Federal Trade Commission (FTC; Washington DC, USA) is also reviewing the deal, following concerns previously raised by consumer groups regarding whether CVS Caremark, the result of a merger between a large drug store chain and a PBM, is hurting competition, and regulators are likely to want to prevent the merger if they have similar worries that it will stifle competition.

“The cost and quality of health care is a great concern to all Americans. We’re going to take a lot of costs out of health care,” said George Paz, chairman and CEO of Express Scripts. “This is the right deal at the right time for the right reasons; we wouldn’t be doing this if we didn’t think we could get it through.”

Upon completion of the transaction, Express Scripts shareholders are expected to own about 59% of the combined company, with Medco shareholders owning about 41%. The combined company's corporate headquarters will be in St. Louis (MO, USA); Express Scripts chief George Paz will serve as chairman and CEO of the combined organization. Express Scripts projected $1 billion in cost savings and other synergies--about 1% of the combined company's costs--and that the deal would slightly add to earnings in the first full year after closing. The merger is expected to close in the first half of 2012.

Related Links:
Express Scripts
Medco Health Solutions
CVS Caremark




New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Cannulating Sphincterotome
TRUEtome
New
Diagnosis Display System
C1216W

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex